Pasithea Therapeutics Corp. (KTTA) Net Income by Year
Pasithea Therapeutics Corp. reported a net loss of $20.4M in fiscal year 2025. This represents a decrease of 46.9% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Pasithea Therapeutics Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KTTA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
KTTA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Pasithea Therapeutics Corp. financials
Frequently Asked Questions
What was Pasithea Therapeutics Corp.'s net income in fiscal year 2025?
Pasithea Therapeutics Corp. reported a net loss of $20.4M in fiscal year 2025.
How fast is Pasithea Therapeutics Corp.'s net income growing?
Pasithea Therapeutics Corp. (KTTA) net income fell by 46.9% year over year, from -$13.9M to -$20.4M in fiscal year 2025.
How has Pasithea Therapeutics Corp.'s net income changed over the years?
Across the 5 fiscal years this page covers, Pasithea Therapeutics Corp. (KTTA) net income went from -$2.2M in fiscal year 2021 to -$20.4M in fiscal year 2025.
What was Pasithea Therapeutics Corp.'s net income in the most recent quarter?
Pasithea Therapeutics Corp. (KTTA) reported -$5.3M in net income in Q2 2026. This represents a decrease of 41.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Pasithea Therapeutics Corp. (KTTA) reported on that line in every period on record.